Assembly Actions -
Lowercase Senate Actions - UPPERCASE |
|
---|---|
Feb 20, 2025 |
referred to higher education |
Senate Bill S5352
2025-2026 Legislative Session
Sponsored By
(D) 14th Senate District
Current Bill Status - In Senate Committee Higher Education Committee
- Introduced
-
- In Committee Assembly
- In Committee Senate
-
- On Floor Calendar Assembly
- On Floor Calendar Senate
-
- Passed Assembly
- Passed Senate
- Delivered to Governor
- Signed By Governor
Actions
2025-S5352 (ACTIVE) - Details
- Current Committee:
- Senate Higher Education
- Law Section:
- Education Law
- Laws Affected:
- Amd §6810, Ed L
- Versions Introduced in 2023-2024 Legislative Session:
-
S8633
2025-S5352 (ACTIVE) - Sponsor Memo
BILL NUMBER: S5352 SPONSOR: COMRIE TITLE OF BILL: An act to amend the education law, in relation to notification of the substitution of one generic drug product for another generic drug PURPOSE OR GENERAL IDEA OF BILL: Requires a prescriber o pha farmcist to notify a patient if the generic drug has changed from aeciously used generic drug. SUMMARY OF SPECIFIC PROVISIONS: Section. 1 establishes the requirement to notify a patient orally and writing if their generic drug has changed. Section 2 provides that act shall take effect 90 days after enactment. JUSTIFICATION:
2025-S5352 (ACTIVE) - Bill Text download pdf
S T A T E O F N E W Y O R K ________________________________________________________________________ 5352 2025-2026 Regular Sessions I N S E N A T E February 20, 2025 ___________ Introduced by Sen. COMRIE -- read twice and ordered printed, and when printed to be committed to the Committee on Higher Education AN ACT to amend the education law, in relation to notification of the substitution of one generic drug product for another generic drug THE PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND ASSEM- BLY, DO ENACT AS FOLLOWS: Section 1. Subdivision 6 of section 6810 of the education law is amended by adding a new paragraph (b-1) to read as follows: (B-1) THE PRESCRIBER OR PHARMACIST SHALL INFORM THE PATIENT WHETHER THEY HAVE PRESCRIBED OR SUBSTITUTED A DIFFERENT GENERIC DRUG PRODUCT FROM THE GENERIC DRUG PRODUCT THE PATIENT HAS PREVIOUSLY RECEIVED. NOTIFICATION REQUIRED PURSUANT TO THIS PARAGRAPH SHALL BE PROVIDED BOTH WRITTEN AND ORALLY. § 2. This act shall take effect on the ninetieth day after it shall have become a law. EXPLANATION--Matter in ITALICS (underscored) is new; matter in brackets [ ] is old law to be omitted. LBD09499-01-5
Comments
Open Legislation is a forum for New York State legislation. All comments are subject to review and community moderation is encouraged.
Comments deemed off-topic, commercial, campaign-related, self-promotional; or that contain profanity, hate or toxic speech; or that link to sites outside of the nysenate.gov domain are not permitted, and will not be published. Attempts to intimidate and silence contributors or deliberately deceive the public, including excessive or extraneous posting/posts, or coordinated activity, are prohibited and may result in the temporary or permanent banning of the user. Comment moderation is generally performed Monday through Friday. By contributing or voting you agree to the Terms of Participation and verify you are over 13.
Create an account. An account allows you to sign petitions with a single click, officially support or oppose key legislation, and follow issues, committees, and bills that matter to you. When you create an account, you agree to this platform's terms of participation.